Pulmonary Hypertension Trial, Recruiting (NCT07236970)

Pulmonary Hypertension Trial, Recruiting NCT07236970 Sponsor: Alejandro Cruz Utrilla Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07236970 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older
You must have been diagnosed with a condition called systemic sclerosis (a disease that affects the skin and internal organs) using standard medical guidelines
If you have systemic sclerosis without a specific type of high blood pressure in the lungs (called pulmonary arterial hypertension), you may qualify as a "control" participant — though some people with certain related lung pressure conditions may also be included in limited numbers (confirm with trial site)
If you have systemic sclerosis with pulmonary arterial hypertension (high blood pressure in the arteries of the lungs), confirmed by a specific heart test called a right heart catheterization showing certain pressure and resistance measurements, you may qualify as a "case" participant

Who may not be able to join:

If important information from your initial diagnosis is missing — such as results from a physical examination, blood tests, a heart tracing (ECG), or an ultrasound of the heart — you may not be eligible
If you are unable to give your own informed consent to take part in the study, you would not be able to join

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07236970

Sponsor: Alejandro Cruz Utrilla

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

More information: https://clinicaltrials.gov/study/NCT07236970

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older
You must have been diagnosed with a condition called systemic sclerosis (a disease that affects the skin and internal organs) using standard medical guidelines
If you have systemic sclerosis without a specific type of high blood pressure in the lungs (called pulmonary arterial hypertension), you may qualify as a "control" participant — though some people with certain related lung pressure conditions may also be included in limited numbers (confirm with trial site)
If you have systemic sclerosis with pulmonary arterial hypertension (high blood pressure in the arteries of the lungs), confirmed by a specific heart test called a right heart catheterization showing certain pressure and resistance measurements, you may qualify as a "case" participant

Who may not be able to join:

If important information from your initial diagnosis is missing — such as results from a physical examination, blood tests, a heart tracing (ECG), or an ultrasound of the heart — you may not be eligible
If you are unable to give your own informed consent to take part in the study, you would not be able to join

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Alejandro Cruz Utrilla

Registry

ClinicalTrials.gov

Start date

30 May 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Diagnostic accuracy of AI-based screening models for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc); Event-free survival in patients with systemic sclerosis-associated PAH; Patient-reported quality of life in systemic sclerosis-associated PAH

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov